遭遇醫生患者艾芬投訴 愛爾眼科(300015.SZ)低開5.19%
格隆匯1月4日丨上個交易日創出歷史新高的愛爾眼科(300015.SZ)今早低開5.19%報71元,最新市值2926億元。12月31日,武漢市中心醫院急診科主任艾芬發文稱,自己右眼患上白內障後,在愛爾眼科醫院接受治療。不料術後視網膜脱落,右眼近乎失明。1月4日,愛爾眼科稱艾芬右眼失明與手術無關。此前1月2日,愛爾眼科集團曾赴武漢進行調查。但調查僅有3分鐘就給出結論。艾芬認為,愛爾醫院所謂的“調查”,其實就只是“走過場”,“根本不是想好好解決問題。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.